GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Net Interest Income

Pharmosa Biopharm (ROCO:6875) Net Interest Income : NT$33.3 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Pharmosa Biopharm's net interest income for the three months ended in Mar. 2025 was NT$8.2 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2025 was NT$33.3 Mil.

Pharmosa Biopharm Net Interest Income Historical Data

The historical data trend for Pharmosa Biopharm's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Net Interest Income Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Interest Income
Get a 7-Day Free Trial -3.82 -1.11 -0.15 6.67 29.66

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.55 7.28 8.25 9.58 8.18

Pharmosa Biopharm Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$33.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm Net Interest Income Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Net Interest Income
Comparable Companies
ROCO:4157 ROCO:4726 TPE:6949 ROCO:4167 TPE:1760 TPE:1734 ROCO:7759 TPE:4142 TPE:6657 ROCO:4178 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.66, Sanchong Road, 3rd Floor-3, Nangang District, Taipei, TWN, 11502
Website
https://www.pharmosa.com.tw
Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology.

Pharmosa Biopharm Headlines

No Headlines